After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...

We built our IPO process in partnership with the investment banking community, ensuring that they have the control and information they need to successfully open your IPO. Nasdaq’s best-in-class ...

Metsera, Inc. aims to raise $275 million in an IPO to fund its clinical-stage biopharma programs targeting obesity and ...

But there were already early signs of bullishness — especially in fintech — thanks to the wildly successful 2024 IPO of ServiceTitan, a SaaS platform for the trades. TechCrunch has compiled a ...

Bally's announced a $250 million public offering last month for shares of its massive Chicago casino project, but only to ...

2024 saw a significant rebound in the IPO market relative to 2023, with nearly 50% more IPOs in 2024 than in the year prior. Syntax Data analyzed the 175 US companies that went public in 2024 ...

The funds raised from the IPO will be used to advance the clinical development of these lead programs. The company is also developing another program, MZE001, for a genetic disorder called Pompe ...

The Bay Area-based biotech revealed the planned IPO in a Jan. 7 filing with the Securities and Exchange Commission but did not divulge how many shares it plans to offer nor at what price.

Groww, India’s largest retail stockbroker, is preparing to file for an IPO in 10 to 12 months, seeking a valuation between $6 billion and $8 billion, sources familiar with the matter told ...